Agios Pharmaceuticals (AGIO) EPS (Basic) (2012 - 2026)
Agios Pharmaceuticals' (AGIO) quarterly EPS (Basic) came in at -$2.41 in Q2 2026, down 5.69% YoY from -$2.55 in Q2 2025, and up 4.22% on a QoQ basis from -$2.51 in Q1 2026.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) EPS (Basic) (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 14 years of EPS (Basic) data on file, last reported at -$2.41 in Q2 2026.
- Quarterly EPS (Basic) fell 5.69% year-over-year to -$2.41 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$8.45 (down 180.48% YoY) and the FY2025 annual result came in at -$7.12, down 160.04% from the prior year.
- EPS (Basic) rose to -$2.41 in Q2 2026, from -$2.51 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $16.65 in Q3 2024 to a low of -$2.51 in Q1 2026.
- A 4-year average of -$0.57 and a median of -$1.75 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 1117.27% — and 2025, when it sank 110.69%.
- Tracing AGIO's EPS (Basic) over 4 years: stood at -$1.72 in 2023, then gained by 1.44% to -$1.7 in 2024, then fell by 9.68% to -$1.86 in 2025, then dropped by 29.19% to -$2.41 in 2026.
- The last three EPS (Basic) figures came in at -$2.41 (Q2 2026), -$2.51 (Q1 2026), and -$1.86 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Agios Pharmaceuticals | 1.98 Bn | 1.98 Bn | 41.75 Mn | -1.69 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.69 |
| Mar 31, 2026 | -1.69 |
| Dec 31, 2025 | -1.86 |
| Sep 30, 2025 | -1.78 |
| Jun 30, 2025 | -1.94 |
| Mar 31, 2025 | -1.58 |
| Dec 31, 2024 | -1.70 |
| Sep 30, 2024 | 16.65 |
| Jun 30, 2024 | -1.72 |
| Mar 31, 2024 | -1.48 |
| Dec 31, 2023 | -1.72 |
| Sep 30, 2023 | -1.64 |
| Jun 30, 2023 | -1.54 |
| Mar 31, 2023 | -1.49 |
| Dec 31, 2022 | -1.69 |
| Sep 30, 2022 | -1.59 |
| Jun 30, 2022 | -1.75 |
| Mar 31, 2022 | -1.84 |
| Dec 31, 2021 | -1.57 |
| Sep 30, 2021 | -1.56 |